Induction of Antigen-Specific Tumor Immunity by Genetic and Cellular Vaccines against MAGE: Enhanced Tumor Protection by Coexpression of Granulocyte-Macrophage Colony-Stimulating Factor and B7-1-Reference-Cited by-同舟云学术

Induction of Antigen-Specific Tumor Immunity by Genetic and Cellular Vaccines against MAGE: Enhanced Tumor Protection by Coexpression of Granulocyte-Macrophage Colony-Stimulating Factor and B7-1

Published:1996-09 Issue:5 Volume:2 Page:545-555
ISSN:1076-1551
Container-title:Molecular Medicine
language:en
Short-container-title:Mol Med

Author:

Büeler Hansruedi,Mulligan Richard C.

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF03401639.pdf

Reference57 articles.

1. Bakker AB, Schreurs MW, de Boer AJ, et al. (1994). Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med. 179: 1005–1009.

2. Boel P, Wildmann C, Sensi ML, et al. (1995). BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 2: 167–175.

3. Boon T, Cerottini JC, Van den Eynde B, van der Bruggen P, Van Pel A. (1994). Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12: 337–365.

4. Brichard V, Van Pel A, Wolfel T, et al. (1993). The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178: 489–495.

5. Castelli C, Storkus WJ, Maeurer MJ, et al. (1995). Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes. J. Exp. Med. 181: 363–368.

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Propolis anti-inflammatory effects on MAGE-1 and retinoic acid-treated dendritic cells and on Th1 and T regulatory cells;Journal of Venomous Animals and Toxins including Tropical Diseases;2023

2. A compact and simple method of achieving differential transgene expression by exploiting translational readthrough;BioTechniques;2022-04

3. Glycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 Infection;Frontiers in Immunology;2021-12-23

4. Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants;Journal of Virology;2021-09-09

5. A summary of current NKG2D-based CAR clinical trials;Immunotherapy Advances;2021-01-01